Areas of Activity#

Here you will find all fields of scholarship for this section.This page is created automatically.

3

  • 3-D printing of implants Go to
A
  • Abdominal imaging Go to
  • Acute and chronic pancreatitis Go to
  • Acute Pancreatitis Go to
  • Acute phase protein response in animals and their use in diagnostic analysis Go to
  • Acute phase proteins Go to
  • Acute respiratory distress syndrome Go to
  • Acute stroke care Go to
  • Adaptive changes in myocardial contractility Go to
  • Adult spindle cell rhabdomyosarcoma (MYOD1) Go to
  • Aging Go to
  • Air Pollution - ozone, PM2.5, NO2 Go to
  • AIR QUALITY AND HEALTH Go to
  • AIRWAY DISEASES Go to
  • Airway pharmacology Go to
  • Allergic asthma Go to
  • Allergic asthma Go to
  • Allergology Go to
  • Allergology Go to
  • Allergy Go to
  • Allergy Go to
  • Angiomatoid fibrous histiocytoma (EWSR1-CREB1/ATF1) Go to
  • Animal health Go to
  • Antibiotic resistance, including epidemiology, phenotypic and genotypic detection Go to
  • Antibiotic Stewardship Go to
  • Antibiotic stewardship Go to
  • Anticoagulant therapy Go to
  • Antimicrobial stewardship and treatment of complicated bacterial and fungal infections Go to
  • Antimicrobial therapy of invasive candidiasis, aspergillosis Go to
  • Antitrypsin and the serpinopathies Go to
  • Apoptosis regulation Go to
  • Applied health research Go to
  • Arts & health Go to
  • Asbestos Exposure: Lung Function – Pathology – Small Airways Dysfunction Go to
  • ASTHMA, ALLERGIES Go to
  • ASTHMA & ALLERGY Go to
  • Asthma Go to
  • Asthma Go to
  • Asthma Outbreaks by Soybean Dust Inhalation: Diagnosis – Pathognesis – Prevention Go to
  • Atherosclerosis Go to
  • Atopic dermatitis Go to
  • Atopic dermatitis Go to
  • Atopic eczema Go to
  • Autoimmune diseases of the skin & psoriasis Go to
  • Autoimmunity Go to
  • Autoinflammatory disorders Go to
B
  • Back pain Go to
  • Basic immunology, focus on CD4 T cells, cytokines and antigen presenting cells Go to
  • Bedside to bench approach - translational medicine Go to
  • Behavioral Medicine Go to
  • Big data, environment and health/wellbeing Go to
  • Biobanking Go to
  • Biological Psychiatry Go to
  • Biologics in Severe Asthma Treatment Go to
  • Biologic therapy Go to
  • Biology Go to
  • Biomarkers and adjunctive immunotherapy of infection Go to
  • Biomarkers Go to
  • Biomarkers of disease of animals Go to
  • Biostatistics Go to
  • Blood coagulation Go to
  • Bone strength Go to
  • Bronchial Challenge Tests: AMP – Histamine – Mannitol – Methacholine – Platelet Acticating Factor Go to
  • Bronchial provocation Go to
C
  • CANCER AND END-OF-LIFE CARE Go to
  • CANCER AND PALLIATIVE CARE Go to
  • Cancer epidemiology Go to
  • Cancer follow-up Go to
  • Cancer genetics Go to
  • Cancer Go to
  • CANCER IMMUNOLOGY AND IMMUNOTHERAPY Go to
  • Cancer, palliative and supportive care Go to
  • Cancer research (primarily psychosocial, symptom, secondary prevention) Go to
  • Cancer staging and classification Go to
  • Cancer survivorship Go to
  • Cancer & work Go to
  • Cardiac rehabilitation and secondary prevention Go to
  • CARDIAC REHABILITATION Go to
  • CARDIOLOGY Go to
  • Cardiovascular comorbidity in rheumatic diseases Go to
  • Cardiovascular disease prevention Go to
  • Cardiovascular Go to
  • CARDIOVASCULAR MEDICINE Go to
  • Cardiovascular medicine Go to
  • Care pathways and the healthcare organization and quality of care Go to
  • Carer Go to
  • Cell adhesion, chemokines and angiogenesis Go to
  • Cell mediated immunity Go to
  • Cellular cardiac electrophysiology Go to
  • Cerebral hemodynamics in stroke-risk diseases and stroke Go to
  • Cerebral palsy Go to
  • Cerebrovascular disease Go to
  • Cerebrovascular disease Go to
  • Chest imaging Go to
  • Chronic fatigue syndrome Go to
  • Chronic illness Go to
  • Chronic obstructive pulmonary disease Go to
  • Chronic obstructive pulmonary disease Go to
  • Chronic Obstructive Pulmonay Disease (COPD): Guidelines – Exacerbations – Physical Activity – Gas Exchange – Pulmonary Vascular Changes Go to
  • Chronic Pancreatitis Go to
  • Circadian biology Go to
  • Circulation Physiology Go to
  • Clinical academic training and careers Go to
  • Clinical and immunopharmacological activities of Biological Responses Modifiers Go to
  • Clinical and molecular immunology Go to
  • Clinical and translational research in acute pancreatitis Go to
  • Clinical and translational research in chronic pancreatitis Go to
  • Clinical and translational research in pancreatic cancer Go to
  • Clinical aspects of dementia Go to
  • Clinical cancer genetics Go to
  • Clinical course of HIV, response to therapy and immune reconstitution as well as on psychosocial issues Go to
  • Clinical electrophysiology Go to
  • Clinical epidemiology Go to
  • Clinical epidemiology Go to
  • Clinical genetics Go to
  • Clinical immunology Go to
  • Clinical infectious diseases Go to
  • Clinical medicine Go to
  • Clinical microbiology Go to
  • CLINICAL NEUROLOGY AND FUNCTIONAL NEUROIMAGING Go to
  • Clinical neurology, with special regard to stroke Go to
  • Clinical neurosciences Go to
  • Clinical pharmacological studies in the field of neurological disorders Go to
  • Clinical pharmacology Go to
  • Clinical pharmacology Go to
  • Clinical pharmacy Go to
  • Clinical pioneer of successful substrate reduction therapy in sphingolipid diseases Go to
  • Clinical research, translational research Go to
  • Clinical trials and systematic reviews, particularly of interventions in children Go to
  • Clinical trials Go to
  • CLINICAL & VETERINARY SCIENCE Go to
  • Cloned causative mutations in the IDH1 and IDH2 genes in enchondroma, central chondrosarcoma and dedifferentiated chondrosarcoma Go to
  • Cloned unique translocation inEwing-like sarcoma (NFATC2) Go to
  • Cognitive neuroscience Go to
  • Cohort Studies Go to
  • Community nursing Go to
  • COMMUNITY NURSING, PALLIATIVE CARE Go to
  • Comparative models across species Go to
  • Complement Biology Go to
  • Complex interventions Go to
  • Computational imaging research Go to
  • Computed tomography Go to
  • Coronary artery disease Go to
  • Coronary artery disease Go to
  • Crossroads in atherosclerosis and osteoporosis Go to
  • CT-imaging Go to
  • Cystic fibrosis, particularly respiratory infections Go to
  • Cytokines Go to
  • Cytokines (macrophage migration inhibitory factor) Go to
  • Cytoskeleton/structural molecules Go to
D
  • Data analysis Go to
  • Dementia care Go to
  • Dementia Go to
  • Dementia Go to
  • Dendritic cells and their subsets Go to
  • DERMATOLOGY AND GENETICS Go to
  • DERMATOLOGY, EPITHELIAL BIOLOGY Go to
  • Dermatology Go to
  • Dermatology Go to
  • DERMATOLOGY Go to
  • Dermatology Go to
  • Dermatology Go to
  • Dermatology Go to
  • Dermatopharmacology Go to
  • Description of a 4-hour therapeutic window in acute ischaemic stroke in man Go to
  • Development and validation of (dynamic) contrast-enhanced magnetic resonance imaging (MRI) of bone and soft tissue tumours Go to
  • Development of biochemical assays for use in veterinary laboratories Go to
  • Development of positron emission tomography for medicine and medical research Go to
  • Diabetes Go to
  • Diabetes Go to
  • Diagnostic sciences Go to
  • Discovered causative somatic genetic background in Chondromyxoid fibroma (GRM1) Go to
  • Disease biomarkers and biomarker probes Go to
  • Doctoral education Go to
  • Drug discovery and development Go to
  • Drug regulation Go to
  • Drug safety Go to
E
  • Early clinical development Go to
  • Early phase clinical trials Go to
  • Early rehabilitation in the acute hospital setting / mobility research Go to
  • Editing, editorial process, publishing, writing Go to
  • Educator, postgraduate teaching Go to
  • Elucidated the tumour suppressor function of EXT1/2 in osteochondroma and peripheral chondrosarcoma Go to
  • Endocrine-exocrine interactions of the pancreas Go to
  • Endocrine oncology Go to
  • Endocrine regulation of fluid and elecrolyte homeostasis Go to
  • Endocrinology Go to
  • ENDOCRINOLOGY, STRESS RESEARCH Go to
  • End of life Go to
  • End-of-life research Go to
  • Endothelial cell dysfunction Go to
  • Endothelial dysfunction and arterial stiffness Go to
  • Environmental and health inequalities Go to
  • Environmental and occupational health and epidemiology Go to
  • ENVIRONMENTAL AND OCCUPATIONAL HEALTH AND EPIDEMIOLOGY, PUBLIC HEALTH, OCEANS AND HUMAN HEALTH Go to
  • Environmental epidemiology and environmental determinants of diseases Go to
  • Environmental epidemiology Go to
  • Enzyme targeting, gene transfer Go to
  • Epidemiological analysis of pancreatic diseases (AP, CP, PC, AIP) Go to
  • Epidemiology Go to
  • Epidemiology Go to
  • EPIDEMIOLOGY Go to
  • Epithelial ion transports of the gastrointestinal tract Go to
  • Ethics Go to
  • Evaluation of person-centred care interventions using controlled designs Go to
  • Evidence based practice Go to
  • Evidence based practice Go to
  • EVIDENCE-BASED SURGERY Go to
  • Evidence-based surgery Go to
  • Evolutionary medicine Go to
  • Evolution Go to
  • Excimer laser for psoriasis and vitiligo Go to
  • EXPERIMENTAL AND CLINICAL STROKE RESEARCH, NEUROSONOLOGY Go to
  • Experimental animal models of infections (endocarditis, osteomyelitis) Go to
  • Experimental behavioral pharmacology Go to
  • Experimental focal ischemia models Go to
  • Experimental medicine Go to
  • Experimental models of neurological disorders (migraine, Parkinson's disease, Huntington's disease, mulitple sclerosis) Go to
  • Extra- and intracranial ultrasound in vascular diseases Go to
F
  • Falls Go to
  • Fibrosis Go to
  • Filaggrin Go to
  • First-in-human studies Go to
  • First therapeutic trials in the hyper-acute phase of ischaemic stroke in man Go to
  • Focus on asthma phenotypes, biomarkers and novel treatments including applications of biologics Go to
  • Food allergy Go to
  • Food safety Go to
  • Functional and structural architecture of the human brain in health and disease Go to
  • Fungal infections in the intensive care unit Go to
G
  • GASTROENTEROLOGY AND HEPATOLOGY Go to
  • GASTROENTEROLOGY, EPITHELIAL ION TRANSPORT Go to
  • Gastroenterology Go to
  • Gastroenterology Go to
  • Gastrointestinal pathology Go to
  • Genetic basis of human disease Go to
  • Genetic epidemiology Go to
  • Genetic epidemiology Go to
  • Genetic medicine Go to
  • Genetic medicine Go to
  • Genetics Go to
  • Genetics Go to
  • Genetics of pancreatitis and pancreatic cancer Go to
  • Genetics of psoriasis Go to
  • Genetics of rheumatic diseases Go to
  • Genomic medicine Go to
  • Genomics Go to
  • Genomics Go to
  • Genomics Go to
  • GERONTOLOGY, FALLS Go to
  • Global health Go to
  • Glucocorticoids Go to
  • Go to
H
  • Haemostasis Go to
  • Healthcare-associated infections, with emphasis on their clinical epidemiology Go to
  • HEALTH CARE ETHICS, CLINICAL QUALITY, EMPOWERING PATIENT EDUCATION Go to
  • HEALTH CARE Go to
  • Healthcare humanities Go to
  • HEALTHCARE MANAGEMENT Go to
  • Health-economics Go to
  • Health effects of air pollution Go to
  • HEALTH INTERVENTIONS Go to
  • Health promotion Go to
  • Health services research Go to
  • Health workforce planning, recruitment, skill-mix and retention Go to
  • Heart failure disease management Go to
  • Heart failure Go to
  • HEPATOLOGY Go to
  • Hepatology, liver disease Go to
  • Hepatopulmonary Syndrome (HPS): Definition – Diagnosis – Management – Pathophysiology Go to
  • Hereditary cancer Go to
  • Hidradenitis suppurativa Go to
  • Hip/Knee/Ankle Go to
  • History of medicine and nursing Go to
  • HIV/AIDS research Go to
  • HIV and mucosal transmission Go to
  • Home care Go to
  • Host genetic factors Go to
  • Human and animal papillomaviruses Go to
  • Human biochemical genetics Go to
  • Human Immunology Go to
  • Human infection models Go to
  • Human molecular genetics Go to
  • Human movement analysis Go to
  • Human resource management Go to
  • Hyper-IgD syndrome Go to
  • Hypertension and renal research Go to
  • Hypertrophic cardiomyopathy Go to
  • Hypoxia effects on mast cells Go to
I
  • ICU Infections Go to
  • Imaging of energy metabolism in focal ischemia Go to
  • Immune modulation and the link between communicable and non-communicable diseases Go to
  • Immunoassay development and validation Go to
  • IMMUNOEPIDEMIOLOGY Go to
  • Immuno-epidemiology Go to
  • Immunology: experimental (translational and basic research) Go to
  • Immunology Go to
  • Immunology Go to
  • Immunology Go to
  • Immunology Go to
  • Immunology of the airways. Go to
  • IMMUNOLOGY/VACCINOLOGY Go to
  • IMMUNOLOGY & VIROLOGY Go to
  • Immunopathology of atopic and nonatopic asthma Go to
  • Immunopathology of pulmonary arterial hypertension Go to
  • Immunopharmacology Go to
  • IMMUNOPHARMACOLOGY Go to
  • Immunosuppressive therapy Go to
  • Immunotherapy Go to
  • Implant biomechanics Go to
  • Increased oncogene expression in response to myocardial overload and during restenosis Go to
  • Individual-patient data meta-analyses Go to
  • Induction of tumor cell senescence by the immune system Go to
  • Infection Control Go to
  • Infection Go to
  • Infections immunocompromised hosts, including neutropenic cancer patients Go to
  • Infections in critically ill patients Go to
  • Infectious diseases Go to
  • INFECTIOUS DISEASES Go to
  • Infectious diseases Go to
  • Infectious diseases Go to
  • Infectious Diseases Go to
  • Infectious diseases Go to
  • Infectious diseases such as tuberculosis, influenza and clinically related questions to bacterial diseases Go to
  • Inflammation Go to
  • Inflammation Go to
  • Inflammation Go to
  • Inflammation Go to
  • Inflammation Go to
  • Inflammatory biomarkers in breath Go to
  • Inflammatory mechanisms: transcriptional control of inflammatory genes, transcription factors, chromatin remodell Go to
  • Inflammatory skin disease Go to
  • Influenza Go to
  • Informing health policy through minimum datasets and clinical information Go to
  • Inherited skin disease Go to
  • Inherited skin disease Go to
  • Inhibitory receptors on cancer cells as target for therapy Go to
  • Innate and adaptive immunity in the airways Go to
  • Innate immune cells in the skin Go to
  • Innate immune responses Go to
  • Innate immunity and host defence to infection Go to
  • Innate immunity Go to
  • Innate Immunity Go to
  • INNATE IMMUNOLOGY Go to
  • Innovative Therapies (targeted therapies for pulmonary hypertension) Go to
  • Innovative Therapies (targeted therapies for severe asthma) Go to
  • Interdisciplinary collaboration Go to
  • Interdisciplinary research Go to
  • Internal medicine Go to
  • INTERNAL MEDICINE Go to
  • Intracellular cardiac electro-mechanical coupling Go to
  • Investigation of chronic multimorbidity Go to
  • Investigation of genetic susceptibility of the pancreas Go to
  • Investigation of newly developed kynurenine-amino-transferase (KAT) knock-out animals Go to
  • Investigation of newly synthesized kynurenic acid analogues in different animal models of neurological disorders Go to
  • Investigation of the pathophysiology and management of both asthma and COPD Go to
  • In vitro activity of newer antimicrobial agents including interactions with other classes of antibiotics Go to
  • In vivo cardiac electrophysiology Go to
  • Involvement of service users and families in care planning in secondary care mental health services Go to
K
  • Keratinizing disorders Go to
  • Keratinizing disorders Go to
  • Keratinizing skin disorders Go to
  • Keratinocyte/epithelial cell biology Go to
  • Keratins Go to
L
  • LABORATORY ANALYSIS Go to
  • Laboratory Sciences Go to
  • Liver disease Go to
  • Low intensity psychological interventions for common mental health conditions (Depression and anxiety) in Primary Mental Health Services Go to
  • Lung cancer Go to
  • Lung cellular and molecular biology Go to
  • Lung function Go to
  • Lung infection Go to
  • Lung physiology Go to
M
  • Macrophage biology Go to
  • Magnetic resonance imaging Go to
  • Mass cytometry and analysis of high dimensional data Go to
  • Mast cell and eosinophil activating and inhibitory receptors Go to
  • Mast cell and eosinophil functions in allergic diseases Go to
  • Mechanism of inflammation in psoriasis Go to
  • Mechanisms and treatment of severe and difficult-to-treat asthma Go to
  • Mechanisms of cell injury in cholestatic and fatty liver disease Go to
  • Mechanisms of corticosteroid resistance Go to
  • Mediators of inflammation, oxidative stress in lung disease Go to
  • Medical consequences of climate changes Go to
  • Medical device development for skin diseases Go to
  • Medical education Go to
  • Medical education Go to
  • MEDICAL IMAGING Go to
  • MEDICAL MICROBIOLOGY Go to
  • Medical oncology with a special interest in lung cancer and breast cancer Go to
  • Medical Psychology Go to
  • MEDICINE, GASTROENTEROLOGY Go to
  • Medicine Go to
  • Medicine Go to
  • Medicine Go to
  • Medicine Go to
  • Medicine Go to
  • Medicine Go to
  • Medicine Go to
  • Membrane proteins Go to
  • Mental health care Go to
  • Mental health Go to
  • MENTAL HEALTH Go to
  • Metabolic syndrome – mechanisms and consequences Go to
  • Metapneumovirus Go to
  • Methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Enterobacteriaceae Go to
  • Microbiology Go to
  • Microbiome and cancer Go to
  • Microbiome Go to
  • Mixed methods research Go to
  • Molecular allergology Go to
  • Molecular allergy diagnostics Go to
  • Molecular and cellular biology Go to
  • Molecular biology Go to
  • Molecular biology Go to
  • Molecular biology in cardiology Go to
  • Molecular biomarkers of migraine (CGRP, PACAP, kynurenines etc.) Go to
  • Molecular biomarkers of multiple sclerosis (catecohlamines, kynurenines, neurofilament etc.) Go to
  • Molecular cardiology Go to
  • Molecular events and Interactions between immunocompetent cells, inflammatory cells, epithelial cells in allergic inflammation and airways remodelling Go to
  • Molecular genetics Go to
  • Molecular genetics Go to
  • Molecular medicine Go to
  • Molecular oncology with a special interest in lung cancer and breast cancer Go to
  • Molecular pathogenesis and genetics of bone and soft tissue sarcomas Go to
  • Molecular pathogenesis of mycobacterial infections Go to
  • Molecular regulation of hepatobiliary ABC transporters and bile acid signalling in cholestatic and fatty liver disease Go to
  • Molecular tools for bacterial epidemiology Go to
  • Molecular toxicity mechanisms of drugs and pesticides, pharmacokinetics, metabolism, P450 isoforms, gene expression profiling Go to
  • Monitoring bovine mastitis by biomarker analysis Go to
  • Multiple sclerosis Go to
  • Musculoskeletal Go to
  • Musculoskeletal modeling Go to
  • Myocardial autocrine function Go to
N
  • Natural immunity Go to
  • NEONATAL NEUROSCIENCE Go to
  • Neonatology Go to
  • Nephrology Go to
  • Neural circulatory studies in sleep and sleep apnea Go to
  • Neurochemical investigations in models of neurological disorders (excitotoxins, peptides, kynurenines) Go to
  • Neurodegeneration Go to
  • Neuroendocrinology Go to
  • Neuroendocrinology Go to
  • Neuroepidemiology Go to
  • Neuroinflammation Go to
  • Neuroprotection Go to
  • Neuropsyhopharmacological drug research and development Go to
  • Neuroscience Go to
  • Neuroscience, neurology, psychiatry, neuroimaging Go to
  • Neurospin facility for neuroimaging research Go to
  • Neutrophil biology Go to
  • New antiallergic drugs and new strategies in the allergic disease treatment Go to
  • New therapies Go to
  • Non-invasive human imaging techniques with positron-emitting isotopes and magnetic resonance Go to
  • Non-specific effects of vaccines: Immune training effects Go to
  • Nosocomial Infections Go to
  • Nuclear medicine Go to
  • NUCLEAR MEDICINE Go to
  • Nuclear medicine Go to
  • Nuclear receptors Go to
  • Nurse staffing and patient safety and quality of care Go to
  • Nursing Go to
  • NURSING Go to
  • Nursing Go to
  • Nursing Go to
  • Nursing leadership Go to
  • Nursing research Go to
  • Nursing research Go to
  • Nursing research Go to
  • Nursing research Go to
  • Nutrition Go to
  • Nutrition Go to
O
  • Obesity Go to
  • Obesity-related hypertension Go to
  • OBESITY, STATISTICS Go to
  • Observational clinical trials in acute pancreatitis (APPLE, PINEAPPLE, EASY, LIFESPAN) Go to
  • Oceans and human health/wellbeing Go to
  • Older people Go to
  • Oncology: experimental and clinical Go to
  • Oncology Go to
  • ORTHOPAEDIC BIOMECHANICS Go to
  • Orthopaedic biomechanics Go to
  • Osteoblastoma (del chrom 22) Go to
  • Osteosarcoma (SMAD and GLI-mediated pathways, del P16 and stem cell tumourigenesis) Go to
P
  • Paediatrics Go to
  • Paediatrics Go to
  • Paediatrics Go to
  • PAEDIATRICS Go to
  • Paediatrics with special interest in childhood asthma and childhood allergies Go to
  • Pain management (musculoskeletal and neuropathic) Go to
  • Palliative care Go to
  • PANCREAS DISEASES Go to
  • Pancreas Go to
  • Pancreatic Cancer Go to
  • Pancreatic ductal adenocarcinoma, adjuvant, neoadjuvant, chemotherapy, necrosectomy, pancreatectomy, PRSS1, SPINK1, hENT1, endoscopic sphincterotomy. Go to
  • Pancreatic surgery Go to
  • Parasitology & neglected and poverty related tropical diseases (helminths and malaria) Go to
  • Parkinson's disease Go to
  • Participatory and Action research Go to
  • Pathogenesis and immunogenetics of invasive fungal infections Go to
  • Pathogenesis and therapy of Lyme Borreliosis Go to
  • Pathogenesis of inflammatory skin diseases Go to
  • Pathogen-host-interactions during infectious diseases in immune-competent and immune-compromised hosts Go to
  • PATHOLOGY BONE TUMOURS Go to
  • Patient and public involvement Go to
  • Patients Reported Outcomes & Quality of life evaluation in patients with respiratory and allergic diseases Go to
  • Pedagogical research Go to
  • Peripheral nerve lesions: diagnosis and treatment Go to
  • Personalised medicine Go to
  • Personalised therapeutics Go to
  • Personalized medicine Go to
  • Pharmacodynamic biomarkers Go to
  • Pharmacoepidemiology Go to
  • Pharmacogenetics Go to
  • Pharmacogenomics Go to
  • Pharmacokinetics and pharmacodynamics Go to
  • Pharmacokinetics/toxicokinetics Go to
  • Pharmacological and toxicological in vivo and in vitro studies with drugs, pesticides, and chemicals and their interpretation. Go to
  • Pharmacological treatment of cholestatic and fatty liver disease Go to
  • Pharmacology and drug therapy Go to
  • Pharmacology Go to
  • Pharmacology of cardiovascular system Go to
  • Pharmacovigilance Go to
  • PHARMACY PHARMACOLOGY Go to
  • Phase I trials across solid tumors Go to
  • Photodermatology Go to
  • Physical and Rehabilitation Medicine Go to
  • Physiology and neuroprotection of the newborn Go to
  • Physiology and pathophysiology of cardiac arrhythmias Go to
  • Physiology and pathophysiology of pancreas Go to
  • Physiotherapy Go to
  • PK/PDs of newer antimicrobial agents Go to
  • Pollutant toxicity Go to
  • Pollution Go to
  • Population genetics Go to
  • Postnatal adaptation Go to
  • Precision medicine Go to
  • Preclinical and clinical research in obstructive airway diseases (Asthma and Chronic Obstructive Pulmonary Disease) Go to
  • Preclinical development of immune checkpoint blockers Go to
  • Prevention and treatment of hypertension, hyperlipidemia, congestive heart failure and diabetes Go to
  • Primary care Go to
  • Prisoner health Go to
  • Protein misfolding diseases Go to
  • Protein purification and analysis for diagnostics Go to
  • Proteins of serum, milk and other biological fluids of domestic animals Go to
  • Proteomics as applied to domestic animals Go to
  • Psoriasis Go to
  • Psoriasis Go to
  • Psychiatric Genetics Go to
  • Psychological therapies Go to
  • Psychometrics Go to
  • Psychosocial interventions Go to
  • Public and patient involvement Go to
  • Public engagement in science Go to
  • Public health Go to
  • Public health, particularly new public health Go to
  • Pulmonary fibrosis Go to
  • Pulmonary Hypertension Go to
  • Pulmonary hypertension Go to
  • Pulmonary hypertension Go to
  • PULMONARY MEDICINE Go to
  • Pulmonary nodules Go to
  • Pulmonary vascular disease Go to
Q
  • Qualitative and quantitative measurements of CBF and CMRO2 in man Go to
  • Qualitative phenotypic change in the overloaded myocardium Go to
  • Quantitative evaluation of cardiac and CNS receptors with PET Go to
R
  • Radiotherapy Go to
  • Randomised clinical trials Go to
  • Randomised controlled trials Go to
  • Randomised controlled trials of complex interventions Go to
  • Randomized interventional clinical trials in acute pancreatitis (GOULASH, PREPAST, EMILY) Go to
  • RARE DISEASES Go to
  • Recognition of microbas by epidermal cells Go to
  • Reflexivity Go to
  • Reflex regulation of cardiovascular system in physiologic and pathologic states Go to
  • Rehabilitation after acute trauma and amputation Go to
  • Rehabilitation Go to
  • REHABILITATION Go to
  • Rehabilitation Go to
  • REHABILITATION MEDICINE Go to
  • Remote delivery of interventions (telephone, computerised therapies) with Chronic Widespread Pain Go to
  • Research assessment Go to
  • Research impact Go to
  • Research in clinical nursing/health care, consisting of analysis and instrumentation Go to
    • Evaluation of the quality of nursing care
    • Competence of nurses for quality care
    • Empowering patient education
  • Research in health care and nursing ethics, consisting of Go to
    • Analysis of the realisation of patients' rights
    • Moral courage and ethical competence of professionals
    • Ethics of leadership
  • Research in nursing/health care education/pedagogics, consisting of Go to
    • Evaluation of outcomes of nursing education
    • Technological educational solutions
    • Professional competence of students.
  • Research methodology Go to
  • Research methodology Go to
  • Research methodology Go to
  • Research methodology Go to
  • Research methodology Go to
  • Research Methods Go to
  • Research strategy and organization Go to
  • Resistance surveillance studies at national level Go to
  • Resistant mechanism of antimicrobial agents Go to
  • Respiratory allergy Go to
  • Respiratory disease Go to
  • Respiratory Diseases Go to
  • RESPIRATORY GENETICS AND GENOMICS Go to
  • RESPIRATORY Go to
  • RESPIRATORY MEDICINE Go to
  • Respiratory medicine Go to
  • Respiratory Medicine Go to
  • Respiratory medicine Go to
  • RESPIRATORY MEDICINE, INFLAMMATION Go to
  • Respiratory Medicine: specifically asthma and chronic obstructive pulmonary disease Go to
  • Respiratory Pharmacology: molecular mechanisms of corticosteroids and bronchodilators Go to
  • RESPIRATORY PHYSIOLOGY AND MEDICINE Go to
  • Respiratory virus infections Go to
  • Rheumatoid arthritis Go to
  • Rheumatology/Arthritis Go to
  • RHEUMATOLOGY. CLINICAL IMMUNOLOGY. Go to
  • Rheumatology Go to
  • Risk assessments evaluation to animals, humans and environment Go to
  • Role of the amygdala in human empathy explored with fMRI Go to
S
  • Safety and efficacy of drugs in children Go to
  • Secondary bone loss in rheumatic diseases Go to
  • Secondary cancer in rheumatic diseases Go to
  • Self care Go to
  • Sepsis Go to
  • Sepsis Go to
  • Septic shock Go to
  • Severe respiratory and food allergy Go to
  • Sex-differences Go to
  • Sex-differential effects of interventions Go to
  • Signal pathways of oxidative stress, apoptosis, inflammation, and DNA methylation and drug therapeutic effect. Go to
  • Skin ageing Go to
  • Skin physiology and pathophysiology Go to
  • Social anthropology Go to
  • Social Innovation Go to
  • Spasticity Go to
  • Specific protein analysis Go to
  • Statistics and clinical trials Go to
  • Stem cells in cardiology Go to
  • Stem cell therapy for severe skin fragility syndromes Go to
  • Steroid metabolism Go to
  • Stratified medicine Go to
  • Stress hormone biology Go to
  • Stroke Go to
  • Stroke Go to
  • Structured reporting Go to
  • Suicide and self harm Go to
  • Suicide and self harm Go to
  • Symptoms Go to
  • Synovial inflammation Go to
  • Systematic review Go to
  • Systemic Lupus Erythematosus Go to
  • Systems pharmacology Go to
T
  • Targets for targeted (biological) therapies Go to
  • The Mast Cell-Eosinophil Allergic Effector Unit Go to
  • Therapeutic approach of infections caused by Multi-drug/Extremely-drug/Pan-drug resistant gram negative bacteria Go to
  • Therapy development/experimental medicine Go to
  • The role of microbiome in acne Go to
  • Thrombin generation Go to
  • Thrombin Go to
  • Thrombosis Go to
  • Tissue repair and fibrosis Go to
  • T Iymphocytes Go to
  • Transgenic models of human disease Go to
  • TRANSLATIONAL MEDICINE Go to
  • Translational medicine Go to
  • Translational medicine Go to
  • Translational neuroscience Go to
  • TRANSLATIONAL ONCOLOGY Go to
  • Translational research Go to
  • Translational research in cardiovascular disease Go to
  • Translation of biomarker and neuropharmacological data from basics to clinic Go to
  • Tumor immune therapy Go to
  • Tumor immunology Go to
  • Tumor vaccine: exosomes, dendritic cells Go to
U
  • University administration Go to
  • Urological cancers Go to
V
  • Vaccination Go to
  • Vaccine development Go to
  • VACCINE RESEARCH Go to
  • Vaccinology Go to
  • Vaccinology Go to
  • Vaccinology Go to
  • Vascular medicine Go to
  • Veterinary biochemistry and particularly veterinary clinical biochemistry Go to
  • Veterinary clinical pathology Go to
  • VETERINARY DIAGNOSTICS Go to
  • Viral immunology Go to
  • Virology Go to
  • Virus associated malignancy Go to
  • Vitamin A supplementation Go to
W
  • Workforce planning and skill mix in health Go to
  • Workforce policy and planning Go to
Imprint Privacy policy « This page (revision-6) was last changed on Tuesday, 1. December 2020, 11:33 by System
  • operated by